Advertisement

Topics

Search Results for "New Treatment For Hepatitis B"

21:04 EDT 25th June 2016 | BioPortfolio

Matching Channels

Hepatitis B

Hepatitis A

Hepatitis C

Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected. Treatment goal is to achieve a sustained virological response (SVR), which is the absence of serum HCV R...

Hepatitis E virus HEV

Hepatitis B virus HBV

Matching News

Deciding on the Best Treatment in Patients With Hepatitis B

Recent recommendations and their impact on the management of patients with hepatitis B, including immune-tolerant hepatitis B, immune-active hepatitis B, and inactive chronic hepatitis, are reviewed. ...

The Hepatitis C Trust considers legal action over cap on NHS patients allowed to seek treatment

NHS England is limiting treatment with new drugs for hepatitis C to 10,000 of the most in-need patients, prompting The Hepatitis C Trust to consider seeking a judicial review of the decision.

Longevity After Hepatitis C Treatment

Before direct-acting antiviral medications came on the scene for treating hepatitis C, this disease was often a death sentence for patients who progressed to liver failure or liver cancer. However, ov...

An Unforeseen Complication of the New Hepatitis C Drugs

Hepatitis B might flare during treatment for hepatitis C.

Ledipasvir/sofosbuvir Treatment in Hepatitis C Virus

What are the changes in the apolipoprotein profile of patients with hepatitis C during and after treatment with ledipasvir and sofosbuvir with and without ribavirin? Journal of Viral Hepatitis

Mycophenolate mofetil effective as first-line treatment for autoimmune hepatitis

In a real-world retrospective study, researchers found mycophenolate mofetil treatment to be safe and effective for the treatment of autoimmune hepatitis in treatment-naive patients, according to publ...

Hepatitis C Treatment Delivery Mandates

This Viewpoint describes how a shortage of health care workers providing treatment for hepatitis C hinders access to treatment, despite progress in drug efficacy and reductions in drug costs.

Pharmalot, Pharmalittle: New $300 hepatitis C treatment in development

A nonprofit is working with an Egyptian drug maker to develop a combination hepatitis C treatment that will sell for less than $300.

Matching PubMed Articles

The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service.

Hepatitis C treatment uptake in Australia is low. To increase access to hepatitis C virus treatment for people who inject drugs, we developed a community-based, nurse-led service that linked a viral h...

The New Era of Interferon-Free Treatment of Chronic Hepatitis C.

Within the development and approval of several new direct-acting antivirals (DAA) against hepatitis C virus (HCV), a new era of hepatitis C therapy has begun. Even more treatment options are likely to...

Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus co-infected patients from Sub-Saharan Africa.

In Sub-Saharan Africa, seroclearance of hepatitis B surface antigen (HBsAg) and hepatitis B "e" antigen (HBeAg), including their quantifiable markers, have rarely been evaluated during long-term antiv...

Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: A randomized controlled trial.

Entecavir (ETV) and Tenofovir Disoproxil Fumarate (TDF) have been considered among the most potent antiviral agents for the treatment of chronic hepatitis B infection. We aimed to compare treatment ef...

Successful treatment of chronic hepatitis C with triple therapy in an opioid agonist treatment program.

People who inject drugs (PWID) constitute 10 million people globally with hepatitis C virus, including many opioid agonist treatment patients. Little data exist describing clinical outcomes for patien...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement